Ethyl Tetradecanoate
CAS 124-06-1
Ethyl Tetradecanoate (CAS 124-06-1) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 2933289.763333333 nM | 3 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ethyl Tetradecanoate used for in pharmaceutical contexts?
Ethyl Tetradecanoate (CAS 124-06-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ethyl Tetradecanoate?
No adverse-event association or SIDER side-effect rows are rendered for Ethyl Tetradecanoate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ethyl Tetradecanoate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ethyl Myristate with EU status "permitted".
What clinical phase is Ethyl Tetradecanoate in?
No phase 1-4 clinical development badge is rendered for Ethyl Tetradecanoate because the matched compound identifier rows do not contain a max-phase value.